DE69626260T2 - Zusammensetzungen zur Vorbeugung und Behandlung von urogenitalen Störungen, die Wismut enthalten - Google Patents

Zusammensetzungen zur Vorbeugung und Behandlung von urogenitalen Störungen, die Wismut enthalten

Info

Publication number
DE69626260T2
DE69626260T2 DE69626260T DE69626260T DE69626260T2 DE 69626260 T2 DE69626260 T2 DE 69626260T2 DE 69626260 T DE69626260 T DE 69626260T DE 69626260 T DE69626260 T DE 69626260T DE 69626260 T2 DE69626260 T2 DE 69626260T2
Authority
DE
Germany
Prior art keywords
prevention
treatment
compositions
containing bismuth
urogenital disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69626260T
Other languages
English (en)
Other versions
DE69626260D1 (de
Inventor
Jamesina Anne Fitzgerald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of DE69626260D1 publication Critical patent/DE69626260D1/de
Application granted granted Critical
Publication of DE69626260T2 publication Critical patent/DE69626260T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/245Bismuth; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69626260T 1995-12-07 1996-12-05 Zusammensetzungen zur Vorbeugung und Behandlung von urogenitalen Störungen, die Wismut enthalten Expired - Fee Related DE69626260T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56885295A 1995-12-07 1995-12-07

Publications (2)

Publication Number Publication Date
DE69626260D1 DE69626260D1 (de) 2003-03-27
DE69626260T2 true DE69626260T2 (de) 2003-12-04

Family

ID=24273004

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69626260T Expired - Fee Related DE69626260T2 (de) 1995-12-07 1996-12-05 Zusammensetzungen zur Vorbeugung und Behandlung von urogenitalen Störungen, die Wismut enthalten

Country Status (8)

Country Link
US (1) US5882686A (de)
EP (1) EP0776665B1 (de)
AT (1) ATE232736T1 (de)
DE (1) DE69626260T2 (de)
DK (1) DK0776665T3 (de)
ES (1) ES2192219T3 (de)
NO (1) NO314979B1 (de)
PT (1) PT776665E (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2767699A1 (fr) 1997-08-28 1999-02-26 Oreal Composition filmogene epaissie

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR962163A (de) * 1950-06-02
US4049817A (en) * 1972-08-14 1977-09-20 Sandoz Ltd. Synergistic compositions
US4514421A (en) * 1979-08-30 1985-04-30 Herschler R J Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
JPS63174926A (ja) * 1987-01-09 1988-07-19 Nitto Kasei Kk 家禽用抗コクシジウム剤
US5221664A (en) * 1990-04-23 1993-06-22 Magainin Pharmaaceuticals Inc. Composition and treatment with biologically active peptides and toxic cations
AU648574B2 (en) * 1990-07-20 1994-04-28 Tillotts Pharma Ag Products and processes for the treatment of the alimentary canal
AUPM596894A0 (en) * 1994-05-30 1994-06-23 Hybrid Scientific Pty Ltd Composition for treating gastrointestinal disorders - a combination of bismuth salts plus lactobacillus or bifidobacteria species bacteria for treating gastrointestinal disorders

Also Published As

Publication number Publication date
NO314979B1 (no) 2003-06-23
EP0776665A1 (de) 1997-06-04
ES2192219T3 (es) 2003-10-01
NO965191D0 (no) 1996-12-05
DE69626260D1 (de) 2003-03-27
ATE232736T1 (de) 2003-03-15
US5882686A (en) 1999-03-16
DK0776665T3 (da) 2003-03-31
NO965191L (no) 1997-06-09
PT776665E (pt) 2003-06-30
EP0776665B1 (de) 2003-02-19

Similar Documents

Publication Publication Date Title
ATE180777T1 (de) 2-aminomethyl-chromane als wirkstoffe in arzneimitteln zur behandlung von erkrankungen des zentralnervensystems
DE60216830D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Störungen des ZNS oder anderen Erkrankungen
DE3852773D1 (de) Zusammensetzungen und Verfahren zur Behandlung von Magen-Darmstörungen.
DK0636027T3 (da) Angiotensin-II-antogonister mod sygdomme forbundet med forringet neuronal ledningshastighed, især diabetisk neuropati
DE69622005T2 (de) Zusammensetzung zur Vorbeugung und Behandlung von urogenitalen Störungen, die Wismut und eine oder mehrere antimikrobielle Mitteln enthalten
ATE116850T1 (de) Mittel zur behandlung von erkrankungen der venen und des analbereichs.
DE69626260D1 (de) Zusammensetzungen zur Vorbeugung und Behandlung von urogenitalen Störungen, die Wismut enthalten
ATE231726T1 (de) Wismuth und eine oder mehrere antimikrobielle mittel enthaltende zusammensetzungen zur verhütung und behandlung gastrointestinaler beschwerden
BR9611927A (pt) Composições contendo bismuto para a prevenção e tratamento de desordens gastrintestinais
ATE212229T1 (de) Bismut und antimikrobielle mittel enthaltende zusammensetzung zur verhütung und behandlung gastrointestinaler beschwerden
ATE211914T1 (de) Wismuth enthaltende zusammensetzungen zur verhütung und behandlung gastrointestinaler beschwerden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee